Novozymes Biopharma announces new study data using Recombumin in protein drug formulation
24-Mar-2010 -
Novozymes Biopharma, part of Novozymes A/S, announced new data which demonstrates extended shelf life of protein drug products using Recombumin, recombinant human albumin. The data, presented for the first time at a recent protein-focused industry event, reveals the potential for Recombumin to ...
albumin
Novozymes
Oxidation
+3